Home > Announcement Board
VM LIU Yanhua Meets with GSK Guests

ViceMinister LIU Yanhua met with President Abbas Hussain of Emerging Markets and President Jean St├ęphenne of Biologicals from GlaxoSmithKline (GSK) on March 31st, 2009.

LIU introduced the development plan and policies related to biomedicine in China. According to him, R&D expenditure on biotechnology including biomedicine from2006 to 2010 amounted to RMB10 billion yuan. MOST encouraged multinational corporations to participate in these R&D programs. Considering the large population and uneven economic development in China, quality and affordability of medicine should be guaranteed.

GSK is planning to invest in vaccine R&D and introduceto China flu vaccine adjuvant and cervical cancer vaccines.